lobbying_activities: 2676394

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2676394	8dd62ee0-f712-43eb-a87d-aa36d3f2c6b5	Q3	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2021	third_quarter	HCR	AACC met House and Senate staff to express opposition to H.R.4128 & S.2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, which would extend Food and Drug Administration oversight to laboratory developed tests (LDTs). AACC joined with other healthcare groups in supporting S.1666, the Verified Innovative Testing in American Laboratories (VITAL) Act, which would codify the existing regulatory model for overseeing LDTs.	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE		90000	0	0	2021-10-05T12:23:59.750000-04:00